Celera Taps Non-Profit Firm to Develop an Axys Candidate

genomeweb
360dx

Celera Taps Non-Profit Firm to Develop an Axys Candidate

Feb 14, 2002

NEW YORK, Feb. 14 - Celera Genomics on Thursday said that the National Institutes of Health and the Institute for OneWorld Health will co-develop a potential drug candidate it gained through its acquisition of Axys Pharmaceuticals.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

People in the News: Michael McCartney, Rohan Hastie, John Ryals, Lawrence Firestone, More
In Brief This Week: Genedrive, Exosome Dx, Luminex, More
CFDRC Acquires Drug-Discovery Division of iXpressGenes
Comprehensive Genetic Testing in Patients With Multiple Tumors Detects Additional Risk Variants
PDL1 Amplifications Mark Subset of Solid Tumors, May Point to Checkpoint Blockade Response
House Committee Proposes 3 Percent Boost to NIH Funding

The Scan

NIH Boost Proposed

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Police, Genealogy, and Privacy

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

Gotta Sequence 'Em All

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

This Week in Science

In Science this week: environmental DNA can help in studies of marine animals, and more.

Main menu